北京力邦生物医药科技

Beijing Libang Biopharmaceutical Technology is a specialized research and development subsidiary of the Xi'an Libang Pharmaceutical Group, focusing on advanced drug delivery systems. The company primarily excels in the development of lipid emulsion technology, which is applied to anesthesia, cardiovascular treatments, and clinical nutrition. Their portfolio includes high-barrier generic and innovative formulations such as Propofol lipid emulsions and Alprostadil injections. By leveraging their expertise in fat emulsion and targeted delivery, they aim to improve the safety and efficacy of critical care medications. The company operates as a key innovation hub within the broader Libang Group's pharmaceutical ecosystem.